US 12,343,322 B2
Composition and method for treating or prophylaxis of coronavirus and cancers
Pablo Antonio Betancourt, Northbrook, IL (US)
Assigned to BETAHEALTH LLC, Northbrook, IL (US)
Filed by BETAHEALTH LLC, Northbrook, IL (US)
Filed on Aug. 26, 2021, as Appl. No. 17/412,523.
Claims priority of provisional application 63/071,128, filed on Aug. 27, 2020.
Claims priority of provisional application 63/104,621, filed on Oct. 23, 2020.
Claims priority of provisional application 63/110,458, filed on Nov. 6, 2020.
Claims priority of provisional application 63/110,485, filed on Nov. 6, 2020.
Prior Publication US 2022/0062219 A1, Mar. 3, 2022
Int. Cl. A61K 38/06 (2006.01); A61K 31/245 (2006.01); A61K 38/46 (2006.01); A61P 11/00 (2006.01)
CPC A61K 31/245 (2013.01) [A61K 38/063 (2013.01); A61K 38/465 (2013.01); A61P 11/00 (2018.01); C12Y 301/21001 (2013.01)] 18 Claims
 
1. A pharmaceutical composition comprising:
about 5-15% by mass procaine or a pharmaceutically acceptable salt thereof;
about 85-95% by mass of a tri- or tetra-peptide comprising one or more glutamate residues or a pharmaceutically acceptable salt thereof;
about 0.01-0.1% by mass DNase 1.